Terms: = Cervical cancer AND ACVR1, SKR1, 90, ENSG00000115170, Q04771, ACVRLK2, FOP, ALK2, ACTRI AND Treatment
1564 results:
1. Comparison of outcomes between early-stage cervical cancer patients without high-risk factors undergoing adjuvant concurrent chemoradiotherapy and radiotherapy alone after radical surgery.
Zhou Y; Wang W; Tang J; Hu K; Zhang F
BMC Cancer; 2024 Apr; 24(1):548. PubMed ID: 38689248
[TBL] [Abstract] [Full Text] [Related]
2. Radiotherapy for patients with esophageal cancer aged 80 years or older: A 16-year experience.
Zhai T; Huang R; Zhan Y; Xu L; Yu Y; Guo L; Chen J; Su C; Chen C
J Cancer Res Ther; 2024 Apr; 20(2):678-683. PubMed ID: 38687940
[TBL] [Abstract] [Full Text] [Related]
3. Interferon-γ-induced GBP1 is an inhibitor of human papillomavirus 18.
Xu M; Lin MC; Li ZH
BMC Womens Health; 2024 Apr; 24(1):240. PubMed ID: 38622605
[TBL] [Abstract] [Full Text] [Related]
4. Effects of bone marrow sparing radiotherapy on acute hematologic toxicity for patients with locoregionally advanced cervical cancer: a prospective phase II randomized controlled study.
Li W; Ma L; Li F; Li K; Zhang Y; Ren H; Bao X; Guo Y; Guo Y; Wang M; Li D; Duan Y; Ma X; Wang Z; Wang Y; Yin R
Radiat Oncol; 2024 Apr; 19(1):46. PubMed ID: 38594678
[TBL] [Abstract] [Full Text] [Related]
5. A Comparative Study of Deep Learning Dose Prediction Models for cervical cancer Volumetric Modulated Arc Therapy.
Wu Z; Liu M; Pang Y; Deng L; Yang Y; Wu Y
Technol Cancer Res Treat; 2024; 23():15330338241242654. PubMed ID: 38584413
[No Abstract] [Full Text] [Related]
6. Predicting treatment plan approval probability for high-dose-rate brachytherapy of cervical cancer using adversarial deep learning.
Gao Y; Gonzalez Y; Nwachukwu C; Albuquerque K; Jia X
Phys Med Biol; 2024 Apr; 69(9):. PubMed ID: 38537309
[No Abstract] [Full Text] [Related]
7. Deep-learning-based radiomics of intratumoral and peritumoral MRI images to predict the pathological features of adjuvant radiotherapy in early-stage cervical squamous cell carcinoma.
Zhang XF; Wu HY; Liang XW; Chen JL; Li J; Zhang S; Liu Z
BMC Womens Health; 2024 Mar; 24(1):182. PubMed ID: 38504245
[TBL] [Abstract] [Full Text] [Related]
8. Preterm Birth Following Active Surveillance vs Loop Excision for cervical Intraepithelial Neoplasia Grade 2.
Lycke KD; Kahlert J; Eriksen DO; Omann C; Pedersen LH; Sundtoft I; Landy R; Petersen LK; Hammer A
JAMA Netw Open; 2024 Mar; 7(3):e242309. PubMed ID: 38483389
[TBL] [Abstract] [Full Text] [Related]
9. Performance of Different Follow-Up Strategies and Genotype-Based Recurrence Risk After treatment of cervical High-Grade Squamous Intraepithelial Lesion.
Graça J; Preti M; Pollano B; Vieira-Baptista P
J Low Genit Tract Dis; 2024 Apr; 28(2):131-136. PubMed ID: 38465957
[TBL] [Abstract] [Full Text] [Related]
10. Uterine transposition for fertility preservation in pelvic cancers.
Ribeiro R; Baiocchi G; Obermair A; Costa CN; Leitao M
Int J Gynecol Cancer; 2024 Mar; 34(3):403-408. PubMed ID: 38438174
[TBL] [Abstract] [Full Text] [Related]
11. The effects of laparoscopic and laparotomy extensive hysterectomy on the safety of ureterovaginal fistula infection in patients with cervical cancer.
Xu H; Ding H; Ge Q; Shi C
Cell Mol Biol (Noisy-le-grand); 2024 Feb; 70(2):281-284. PubMed ID: 38431837
[TBL] [Abstract] [Full Text] [Related]
12. Adherence to treatment and Follow-Up of Precancerous cervical Lesions in Ethiopia.
Stroetmann CY; Gizaw M; Alemayehu R; Wondimagegnehu A; Rabe F; Santos P; Mchome B; Mmbaga BT; Addissie A; Kantelhardt EJ
Oncologist; 2024 May; 29(5):e655-e664. PubMed ID: 38394385
[TBL] [Abstract] [Full Text] [Related]
13. Impact of histological subtypes on clinical outcome of endocervical adenocarcinoma.
Tian X; Liu P; Kang S; Cui Z; Sun L; Lang J; Chen C
Eur J Surg Oncol; 2024 Apr; 50(4):107977. PubMed ID: 38373385
[TBL] [Abstract] [Full Text] [Related]
14. treatment for locally resectable stage IIIC1r cervical cancer: surgery or chemoradiotherapy?
Zhong ML; Liu YC; Yang JT; Wang YN; Ao MH; Xiao Y; Zeng SY; Liang MR
BMC Cancer; 2024 Feb; 24(1):217. PubMed ID: 38360572
[TBL] [Abstract] [Full Text] [Related]
15. Prevalence of PD-L1 in cervical cancer Patients and the Potential for Combining an Immune Checkpoint Inhibitor With Lenvatinib.
Bräutigam K; Schmidt T; Baur M; Tauber N; Kontomanolis EN; Hemptenmacher F; Rody A; Köster F
Anticancer Res; 2024 Feb; 44(2):503-510. PubMed ID: 38307554
[TBL] [Abstract] [Full Text] [Related]
16. Risk of cervical Abnormalities for Women With Multiple Sclerosis Treated With Moderate-Efficacy and High-Efficacy Disease-Modifying Therapies.
Bridge F; Brotherton J; Stankovich J; Sanfilippo PG; Skibina OG; Buzzard K; Kalincik T; Nguyen AL; Guo K; Monif M; Wrede CD; Rath L; Taylor L; Butzkueven H; Jokubaitis VG; Van Der Walt A
Neurology; 2024 Feb; 102(4):e208059. PubMed ID: 38306594
[TBL] [Abstract] [Full Text] [Related]
17. Analysis of age-specified and genotype distribution of HPV multiple infections in the Chinese population.
Zhou YX; Ma XH; Wang TT; Qu XL; Zhang XQ
Sci Rep; 2024 Feb; 14(1):2678. PubMed ID: 38302588
[TBL] [Abstract] [Full Text] [Related]
18. Assessing the relationship between coverage of essential health services and poverty levels in low- and middle-income countries.
Guerra S; Roope LS; Tsiachristas A
Health Policy Plan; 2024 Feb; 39(2):156-167. PubMed ID: 38300510
[TBL] [Abstract] [Full Text] [Related]
19. The impact of text message reminders on cryotherapy uptake among women testing positive for HPV in western Kenya: a prospective cohort study.
Choi Y; Ibrahim S; Park LP; Bukusi EA; Huchko MJ
BMC Womens Health; 2024 Jan; 24(1):32. PubMed ID: 38218782
[TBL] [Abstract] [Full Text] [Related]
20. Epidemiology of cervical cancer in Iran in 2016: A nationwide study of incidence and regional variation.
Anjam Majoumerd A; Hosseini S; Hosseini SMH; Roshandel G; Rahmanian V; Hazar N
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1973. PubMed ID: 38214217
[TBL] [Abstract] [Full Text] [Related]
[Next]
